Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 2:16:131-137.
doi: 10.2147/TACG.S404695. eCollection 2023.

Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia

Awol Mekonnen Ali  1 , Haileyesus Adam  2 , Daniel Hailu  2 , Rawleigh Howe  3 , Teferra Abula  1 , Marieke J H Coenen  4
Affiliations

Evaluating the Frequencies of CNOT3, GRIA1, NFATC2, and PNPLA3 Variant Alleles and Their Association with L-Asparaginase Hypersensitivity in Pediatric Acute Lymphoblastic Leukemia in Addis Ababa, Ethiopia

Awol Mekonnen Ali et al. Appl Clin Genet. .

Abstract

Introduction: L-asparaginase is a vital component for the treatment of childhood acute lymphoblastic leukemia (ALL); however, hypersensitivity reactions and hepatotoxicity hinder its anti-neoplastic efficacy. Previous reports indicated that genetic variants in CNOT3, GRIA1, and NFATC2 genes might be associated with hypersensitivity reactions and PNPLA3 with liver function.

Objective: In this study, it was investigated whether this association also exists in a pediatric ALL cohort from Ethiopia.

Methods: Three variants GRIA1 rs4958351, CNOT3 rs73062673, and NFATC2 rs6021191 were genotyped in a cohort of 160 patients. Association analysis to investigate the association with hypersensitivity reactions was performed using logistic regression analyses. Besides these variants, a variant in PNPLA3 (rs738409) was genotyped to assess the association with liver function.

Results: Genotype frequencies of GRIA1 rs4958351, CNOT3 rs73062673, and NFATC2 rs6021191 were higher/lower than previously reported. One hundred and forty-four patients were included in the association analysis of which, 18 (12.5%) developed L-ASP hypersensitivity. Though the frequency of hypersensitivity was higher in patients that carried the risk alleles of the three investigated genes, no statistically significant differences were observed. Association analysis between PNPLA3 rs738409 and liver function could not be investigated due to a lack of clinical information.

Conclusion: In conclusion, none of the tested genes did predict L-asparaginase hypersensitivity in an Ethiopian pediatric ALL patients.

Keywords: L-asparaginase; acute lymphoblastic leukemia; hypersensitivity.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Frequency of L-ASP hypersensitivity in relation to the investigated SNPs. For each SNP the reference genotype is depicted in the first bar. (A) GRIA1 rs4958351 (B) CNOT3 rs73062673 (C) NFATC2 rs6021191.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Batool T, Makky EA, Jalal M, Yusoff MM. A comprehensive review on l-asparaginase and its applications. Appl Biochem Biotechnol. 2016;178(5):900–923. doi: 10.1007/s12010-015-1917-3 - DOI - PubMed
    1. Fu CH, Sakamoto KM. PEG-asparaginase. Expert Opin Pharmacother. 2007;8(12):1977–1984. doi: 10.1517/14656566.8.12.1977 - DOI - PubMed
    1. Pieters R, Hunger SP, Boos J, et al. L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer. 2011;117(2):238–249. doi: 10.1002/cncr.25489 - DOI - PMC - PubMed
    1. Brumano LP, da Silva FVS, Costa-Silva TA, et al. Development of L-asparaginase biobetters: current research status and review of the desirable quality profiles. Front Bioeng Biotechnol. 2019;6:212. doi: 10.3389/fbioe.2018.00212 - DOI - PMC - PubMed
    1. Egler RA, Ahuja SP, Matloub Y. L-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother. 2016;7(2):62–71. doi: 10.4103/0976-500X.184769 - DOI - PMC - PubMed